CD274 and neoplasm: Immunomodulatory factors within the tumor microenvironment (TME), including PD-L1 expression, T-cell infiltration, tumor mutational burden (TMB), and HLA expression, have been widely reported to correlate with immunotherapeutic responses [14–18].